SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891020-07-000158
Filing Date
2007-05-21
Accepted
2007-05-21 06:03:00
Documents
5
Period of Report
2007-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v30541e8vk.htm 8-K 43281
2 EXHIBIT 10.1 v30541exv10w1.htm EX-10.1 44834
3 EXHIBIT 99.1 v30541exv99w1.htm EX-99.1 3114
4 GRAPHIC v30541v3054101.gif GRAPHIC 4460
5 GRAPHIC v30541v3054102.gif GRAPHIC 7892
  Complete submission text file 0000891020-07-000158.txt   110298
Mailing Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011
Business Address 18701 120TH AVENUE NE SUITE 100 BOTHELL WA 98011 4256083008
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-33393 | Film No.: 07866350
SIC: 2834 Pharmaceutical Preparations